NPI registry status
Active
2026 NPPES data Internal Medicine Physician NPI 1205881620 M.D.
Verify on CMS → Fadi Al-Bilbeisi, M.D.
Internal Medicine Physician in North Smithfield, Rhode Island.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 174,792 in Internal Medicine Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 299 beneficiaries · Internal Medicine Physician avg: 3K
Generic prescribing
32%
generic claims · 68% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$51.99
3 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Fadi Al-Bilbeisi, M.D. filed 2,662 Medicare Part D claims in 2024 as an Internal Medicine Physician in North Smithfield, Rhode Island, prescribing 32% generic.
- 3K
- Part D claims, 2024
- 32%
- generic prescribing
- Likely
- board-certified (heuristic)
- ≥87th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Fadi Al-Bilbeisi, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1205881620), first enumerated 05/24/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,662 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$51.99 in reported industry payments (3 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1205881620 · Internal Medicine Physician
NPI-10 · ENUM-LEGACY · TAX-MEGA · RX-MID · BOOK-LIGHT · PHOTO-ENUM
- NPI-10 1205881620
- ENUM-LEGACY 2006
- TAX-MEGA 175K Internal Medicine
- RX-MID 2,662
- BOOK-LIGHT 1,080 in Rhode Island
- PHOTO-ENUM Randall Haas · 2006
Fadi Al-Bilbeisi, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
2,662 ≥ 87th percentile 87% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
✓
Board certification likely (heuristic, not verified)
Fadi Al-Bilbeisi, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Fadi Al-Bilbeisi, M.D.?
Quality data not reportedPrimary specialty
Internal Medicine Physician
Medicare Part D claims
2,662 4% vs specialty avg
Specialty distribution in Rhode Island
How Internal Medicine Physician compares to other specialties among Rhode Island providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Internal Medicine Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1205881620 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/24/2006 |
Hospital and facility affiliations
Facilities where Fadi Al-Bilbeisi, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Prime Healthcare Services Landmark LLC
Woonsocket, RI
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Fadi Al-Bilbeisi, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$52
Largest payer
GlaxoSmithKline, LLC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Fadi Al-Bilbeisi, M.D. - brand share 68.0%
Internal Medicine Physician average
68% brand-name claims vs 32% generic, on 2,662 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,662
Total Claims
$780K
Total Drug Cost
299
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,450.533
- Total Day Supply
- 95,335
- Brand vs Generic
- 68% brand / 32% generic
- Brand Drug Cost
- $757K
- Generic Drug Cost
- $23K
- Antibiotic Claims
- 161
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 1.81
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 35, 65-74: 120, 75-84: 104, 85+: 40
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Fadi Al-Bilbeisi, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
489 claims
- Trelegy Ellipta
Trelegy Ellipta
374 claims
- Breo Ellipta
Breo Ellipta
239 claims
- Prednisone 193
Prednisone
193 claims
- Arnuity Ellipta 182
Arnuity Ellipta
182 claims
- Montelukast Sodium 171
Montelukast Sodium
171 claims
- Ventolin Hfa 150
Ventolin Hfa
150 claims
- Incruse Ellipta 128
Incruse Ellipta
128 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 489 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 374 |
| Breo Ellipta Fluticasone/Vilanterol | 239 |
| Prednisone | 193 |
| Arnuity Ellipta Fluticasone Furoate | 182 |
| Montelukast Sodium | 171 |
| Ventolin Hfa Albuterol Sulfate | 150 |
| Incruse Ellipta Umeclidinium Bromide | 128 |
| Azithromycin | 97 |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 70 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How Fadi Al-Bilbeisi, M.D. fits within the Internal Medicine Physician landscape nationally.
174,792
Internal Medicine Physician Providers in US
56
States with Internal Medicine Physician
2,785
Avg Claims per Provider
Fadi Al-Bilbeisi, M.D.'s 2,662 claims are below the specialty average of 2,785.
Nationwide Internal Medicine Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Al-Bilbeisi, both outside Rhode Island so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Internal Medicine Physician Providers in Rhode Island
Other clinicians with the same primary specialty enrolled in Rhode Island, drawn from the same CMS NPPES roster as Al-Bilbeisi.
One of 1,080 Internal Medicine Physician providers enrolled in Rhode Island, 5 are shown here.
Salvatore Abbruzzese
D.O. PC
Wakefield, RI
Dr. Azamat Abdyraimov
MD
Providence, RI
Dr. Marie Abejuela
MD
Providence, RI
Dr. Joanna Abi Chebl
MD
Providence, RI
Dr. Reshma Abraham
MD
Warwick, RI
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Fadi Al-Bilbeisi, M.D.'s specialty? ▼
Fadi Al-Bilbeisi, M.D. specializes in Internal Medicine Physician and practices in North Smithfield, Rhode Island. Credentials: M.D..
How much does Fadi Al-Bilbeisi, M.D. prescribe under Medicare Part D? ▼
In 2024, Fadi Al-Bilbeisi, M.D. wrote 2,662 Medicare Part D claims totaling $780K in drug costs for 299 beneficiaries.
Where is Fadi Al-Bilbeisi, M.D. located? ▼
Fadi Al-Bilbeisi, M.D. is located at 63 EDDIE DOWLING HWY, North Smithfield, RI, 02896. Phone: (401) 369-3657.
What is Fadi Al-Bilbeisi, M.D.'s NPI number? ▼
Fadi Al-Bilbeisi, M.D.'s National Provider Identifier (NPI) is 1205881620, issued on 05/24/2006.
Does Fadi Al-Bilbeisi, M.D. prescribe more brand-name or generic drugs? ▼
Fadi Al-Bilbeisi, M.D.'s prescribing is 68% brand-name and 32% generic drugs by claim count, with $757K in brand drug costs.
How many Internal Medicine Physician providers are there in the US? ▼
There are 174,792 Internal Medicine Physician providers across 56 states in the US. The average Internal Medicine Physician provider writes 2,785 Medicare Part D claims per year.
What drugs does Fadi Al-Bilbeisi, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Fadi Al-Bilbeisi, M.D.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Trelegy Ellipta, Breo Ellipta. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Fadi Al-Bilbeisi, M.D. accept Medicare? ▼
Fadi Al-Bilbeisi, M.D. appears in CMS Medicare data with 2,662 Part D claims and 299 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Fadi Al-Bilbeisi, M.D.'s credentials? ▼
Fadi Al-Bilbeisi, M.D.'s NPI is 1205881620 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.